BCYC
Price
$11.66
Change
-$0.34 (-2.83%)
Updated
Feb 21 closing price
Capitalization
805.08M
9 days until earnings call
FHTX
Price
$5.23
Change
-$0.15 (-2.79%)
Updated
Feb 21 closing price
Capitalization
290.85M
11 days until earnings call
Ad is loading...

BCYC vs FHTX

Header iconBCYC vs FHTX Comparison
Open Charts BCYC vs FHTXBanner chart's image
Bicycle Therapeutics
Price$11.66
Change-$0.34 (-2.83%)
Volume$488.87K
Capitalization805.08M
Foghorn Therapeutics
Price$5.23
Change-$0.15 (-2.79%)
Volume$183.5K
Capitalization290.85M
BCYC vs FHTX Comparison Chart
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. FHTX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and FHTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (BCYC: $11.66 vs. FHTX: $5.23)
Brand notoriety: BCYC and FHTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 141% vs. FHTX: 113%
Market capitalization -- BCYC: $805.08M vs. FHTX: $290.85M
BCYC [@Biotechnology] is valued at $805.08M. FHTX’s [@Biotechnology] market capitalization is $290.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileFHTX’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • FHTX’s FA Score: 0 green, 5 red.
According to our system of comparison, BCYC is a better buy in the long-term than FHTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while FHTX’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 3 bearish.
  • FHTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than FHTX.

Price Growth

BCYC (@Biotechnology) experienced а -7.09% price change this week, while FHTX (@Biotechnology) price change was -14.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

BCYC is expected to report earnings on May 01, 2025.

FHTX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($805M) has a higher market cap than FHTX($291M). FHTX YTD gains are higher at: 10.805 vs. BCYC (-16.714). FHTX has higher annual earnings (EBITDA): -98.53M vs. BCYC (-160.02M). BCYC has more cash in the bank: 891M vs. FHTX (267M). BCYC has less debt than FHTX: BCYC (11.1M) vs FHTX (39.1M). BCYC has higher revenues than FHTX: BCYC (36.9M) vs FHTX (25.5M).
BCYCFHTXBCYC / FHTX
Capitalization805M291M277%
EBITDA-160.02M-98.53M162%
Gain YTD-16.71410.805-155%
P/E RatioN/AN/A-
Revenue36.9M25.5M145%
Total Cash891M267M334%
Total Debt11.1M39.1M28%
TECHNICAL ANALYSIS
Technical Analysis
BCYCFHTX
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 5 days ago
81%
Bullish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Ad is loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NUEIX21.45-0.40
-1.83%
Northern US Quality ESG I
CUSIX13.72-0.33
-2.35%
Cullen Small Cap Value I
SELCX43.89-1.12
-2.49%
SEI Large Cap Growth F (SIMT)
VYMSX19.30-0.51
-2.57%
Voya Mid Cap Research Enhanced Index I
BGSCX52.35-1.59
-2.95%
BlackRock Technology Opportunities Inv C

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with RPTX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-2.83%
RPTX - BCYC
48%
Loosely correlated
-2.27%
INO - BCYC
42%
Loosely correlated
+0.90%
XNCR - BCYC
41%
Loosely correlated
-0.32%
RLAY - BCYC
37%
Loosely correlated
-4.16%
FHTX - BCYC
37%
Loosely correlated
-2.79%
More

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with ABOS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
-2.79%
ABOS - FHTX
47%
Loosely correlated
+0.72%
AVIR - FHTX
45%
Loosely correlated
-1.59%
ATXS - FHTX
43%
Loosely correlated
-0.15%
KRYS - FHTX
41%
Loosely correlated
+2.87%
XNCR - FHTX
41%
Loosely correlated
-0.32%
More